Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Fonar Corporation (FONR) Stock Forecast & Price Prediction United States | NASDAQ | Healthcare | Diagnostics & Research
$15.85
-0.29 (-1.80%)Did FONR Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if FONAR is one of their latest high-conviction picks.
FONR has shown a year-to-date change of 4.7% and a 1-year change of -4.7%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for FONR. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for FONR.
Date | Firm | Analyst | Rating | Change | Price Target |
---|
The following stocks are similar to FONAR based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Fonar Corporation has a market capitalization of $99.98M with a P/E ratio of 12.7x. The company generates $103.02M in trailing twelve-month revenue with a 8.2% profit margin.
Revenue growth is +5.6% quarter-over-quarter, while maintaining an operating margin of +13.5% and return on equity of +6.9%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Develops advanced MRI scanners and imaging equipment.
Fonar Corporation generates revenue by manufacturing and selling MRI scanners and related medical imaging equipment to healthcare providers such as hospitals and diagnostic centers. Their innovative products, which allow for multi-position scanning, enhance diagnostic capabilities and improve patient outcomes, making them essential for modern medical practices.
Founded in 1978, Fonar Corporation was a pioneer in MRI technology, creating the first MRI scanner and continuing to drive advancements in the field. Based in Melville, New York, the company is a key player in medical imaging, emphasizing research and development to meet the evolving needs of healthcare professionals.
Healthcare
Diagnostics & Research
520
Mr. Timothy R. Damadian M.D.
United States
1993
SAP gains on cloud strength, NVO faces obesity setbacks, and TMO leans on AI and innovation amid macro headwinds.
FONAR Corporation received a preliminary proposal for acquisition from a group led by Timothy Damadian, offering a price at least 10% above the average share price over the past 90 days.
A proposed acquisition at a premium signals potential value appreciation for FONAR shareholders, indicating confidence in the company's future and possible changes in management strategy.
FONAR Corporation (NASDAQ: FONR) appointed Mr. Robert M. Carrino as an independent director on July 2, 2025.
The appointment of Robert M. Carrino as an independent director could enhance governance and strategic direction at FONAR, potentially influencing investor confidence and stock performance.
FONAR Corporation reported increased net income and revenue for Q3 fiscal 2025, attributed to record MRI scan volumes and robust performance from its HMCA unit.
FONAR's Q3 results indicate robust financial health with increased net income and revenue, signaling potential for growth and profitability, which can boost investor confidence and stock valuation.
Net Income rose 25% to $3.1 million for Q1 2025, while Income from Operations decreased 2% to $3.7 million compared to Q1 2024.
Net Income growth indicates strong profitability, while a slight decline in Operating Income may raise concerns about core business performance. Balancing these factors is crucial for valuation.
FONAR's Q2 fiscal 2025 revenues and net income have declined due to increased costs and reduced scan volumes.
FONAR's declining revenues and net income indicate potential financial instability, raising concerns about profitability and future performance impacting investor confidence.
MRI scan volume at HMCA managed sites rose 7% to 79,207 in the six months ended December 31, 2024. In contrast, volume at HMCA owned sites fell 4% to 26,961 scans.
Increased MRI scan volume at managed sites signals growth potential, while the decrease at owned sites may raise concerns about operational efficiency and profitability.
Analyst forecasts for Fonar Corporation (FONR) are not currently available. The stock is trading at $15.85.
Analyst ratings for FONR are not currently available. The stock is currently trading at $15.85. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for FONR are not currently available. The stock is trading at $15.85.
Fonar Corporation generates revenue by manufacturing and selling MRI scanners and related medical imaging equipment to healthcare providers such as hospitals and diagnostic centers. Their innovative products, which allow for multi-position scanning, enhance diagnostic capabilities and improve patient outcomes, making them essential for modern medical practices.
Price targets from Wall Street analysts for FONR are not currently available. The stock is trading at $15.85.
Price targets from Wall Street analysts for FONR are not currently available. The stock is trading at $15.85.
Analyst ratings for FONR are not currently available. The stock is trading at $15.85.
Stock price projections, including those for Fonar Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.